Stocks Under $5: Blossoming Biotech Play

Portfolio manager David Peltier discusses how to play one the most volatile low-dollar stocks of 2012.
Author:
Publish date:

David Peltier is a research associate at TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks. He also doesn't invest in hedge funds or other private investment partnerships. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Peltier appreciates your feedback;

click here

to send him an email.